Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001667 · ClinicalTrials.gov registry record
Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
A clinical trial of Movement Disorders and Nervous System Diseases, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00001667 is a study of Movement Disorders and Nervous System Diseases that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 300 participants, below the 1,056-participant average among 26 other Movement Disorders trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001667, a study of Movement Disorders and Nervous System Diseases, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to identify families with inherited neurologic conditions, especially movement disorders, to evaluate affected and unaffected individuals clinically, and to obtain blood samples for genetic analysis.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 1997-03 |
| Est. Completion | 2000-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001667
The ClinicalTrials.gov registry entry for NCT00001667 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,056-participant average among 26 other Movement Disorders trials with a reported enrollment target (72% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Movement Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT00001667 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001667 about?
NCT00001667 is a clinical study titled "Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases". The purpose of this protocol is to identify families with inherited neurologic conditions, especially movement disorders, to evaluate affected and unaffected individuals clinically, and to obtain blood samples for genetic analysis.
What is the current status of trial NCT00001667?
This trial is currently completed. The enrollment target is 300 participants. The study started on 1997-03. Estimated completion is 2000-04.
What conditions does trial NCT00001667 study?
This clinical trial studies the following conditions: Movement Disorders, Nervous System Diseases, Tremor, Tic Disorders, Myoclonus.
Who is sponsoring clinical trial NCT00001667?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001667 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Movement Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
RECRUITING · NA
-
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
RECRUITING
-
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
RECRUITING
-
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
RECRUITING
-
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.